IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
J. Clin. Invest. 103:9 doi:10.1172/JCI5703
[Go to this article.]
Options: View larger image (or click on image)
Medium
Figure 3

Effect of neutralizing antibody against IL-17 on OCL formation in cocultures of mouse bone marrow cells and osteoblasts in the presence of IL-17 (1 ng/mL), 1α,25(OH)2D3 (10–8 M), PTH (200 ng/mL), and IL-1β (10 ng/mL). Concentrations of antibody against IL-17 were 2.5 μg/mL for experiments with IL-17 and 5 μg/mL for those with 1α,25(OH)2D3, PTH, and PGE2. After culture for 6 days, TRAP-positive OCLs were counted. Data are expressed as the means ± SEM of quadruplicate cultures. Experiments were repeated 5 times with similar results.